欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
BMS-986020 sodium_1380650-53-2_产品详情
1380650-53-2
  • BMS-986020 sodium

  • names:

    BMS-986020 sodium

  • CAS号:

    1380650-53-2

    MDL Number:
  • MF(分子式): C29H25N2NaO5 MW(分子量): 504.51
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
BMS-986020 sodium
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM003875-5mg 5mg 99.6% ¥ 2970.00 ¥ 2970.00 2-3天
- +
¥ 0.00
YZM003875-1mg 1mg 99.6% ¥ 1287.00 ¥ 1287.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1380650-53-2
Inchi
InchiKey
分子式 Formula C29H25N2NaO5
分子量 Molecular Weight 504.51
溶解度Solubility 生物体外In Vitro:DMSO溶解度150 mg/mL(297.32 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble)
性状
储藏条件 Storage conditions 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months月; -20°C, 1 month月 (sealed storage, away from moisture)
BMS-986020 sodium(CAS:1380650-53-2)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 BMS-986020 sodium 为高亲和力溶血磷脂酸受体 1 (LPA1) 拮抗剂
IntroductionBMS86020 sodium is a highffinity lysophosphatidic acid receptor 1 (LPA1) antagonist. BMS86020 sodium inhibits bile acid and phospholipid transporters withIC50s of 4.8 μM, 6.2 μM, and 7.5 μM for BSEP, MRP4, and MDR3, respectively[2]. BMS86020 sodium is used for the treatment of idiopathic pulmonary fibrosis (IPF)[3].
Application1
Application2
Application3
BMS-986020 sodium 为高亲和力溶血磷脂酸受体 1 (LPA1) 拮抗剂。BMS-986020 sodium 抑制胆汁酸和磷脂转运蛋白,抑制 BSEP,MRP4 和 MDR3,IC50值分别为 4.8 μM,6.2 μM 和 7.5 μM。BMS-986020 sodium 用于治疗特发性肺纤维化 (IPF)。BMS-986020 sodium is a high-affinity lysophosphatidic acid receptor 1 (LPA1) antagonist[1]. BMS-986020 sodium inhibits bile acid and phospholipid transporters withIC50s of 4.8 μM, 6.2 μM, and 7.5 μM for BSEP, MRP4, and MDR3, respectively[2]. BMS-986020 sodium is used for the treatment of idiopathic pulmonary fibrosis (IPF)[3].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Kihara Y, et al. Lysophospholipid receptors in drug discovery. Exp Cell Res. 2015 May 1;333(2):171-7.
【2】.Glenn Rosen, et al. LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis. European Respiratory Journal.
【3】.Palmer SM, et al. Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis. Chest. 2018 Nov;154(5):1061-1069.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents